UTAH MEDICAL PRODUCTS INC UTMD
Nasdaq · XNAS · stock · Surgical & Medical Instruments & Apparatus · website · IPO 1982-12-01
UTAH MEDICAL PRODUCTS INC financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $38.5M | $40.9M | $50.2M | $52.3M | $49.1M |
| Gross profit | $22.0M | $24.1M | $30.0M | $32.2M | $30.9M |
| R&D expense | $668,000 | $813,000 | $560,000 | $493,000 | $526,000 |
| Operating income | $11.4M | $13.6M | $16.8M | $19.8M | $18.9M |
| Income tax | $2.8M | $2.9M | $3.5M | $4.2M | $4.3M |
| Operating cash flow | $14.7M | $14.8M | $22.3M | $21.1M | $21.2M |
| Free cash flow | $14.3M | $14.6M | $21.6M | $20.3M | $20.7M |
| Cash & equivalents | $85.8M | $83.0M | $92.9M | $75.1M | $61.0M |
| Inventory | $7.9M | $8.8M | $9.6M | $8.8M | $6.6M |
| Total assets | $122.5M | $122.5M | $135.5M | $123.9M | $115.6M |
| Total liabilities | $3.3M | $5.1M | $7.1M | $9.6M | $8.5M |
| Shareholders' equity | $119.3M | $117.4M | $128.3M | $114.3M | $107.1M |
| EPS (diluted) | $3.48 | $3.96 | $4.57 | $4.52 | $4.04 |
Source: SEC EDGAR filings · CIK 0000706698 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.